The Beneficial Effect of TJ-134 for Patients With Symptomatic Pneumatosis Cystoides Intestinalis

Recruiting now · Not applicable

Conditions studied: Pneumatosis Cystoides Intestinalis

In brief

The traditional Japanese medicine, Keishi-ka-shakuyaku-daio-to is administered to patients with symptomatic pneumatosis cystoides intestinalis (PCI) as compared with lactomin for 8 weeks.

Key facts

Study ID

NCT04368663

Run by

Showa Inan General Hospital

People needed

100

Starts

2020-05-01

Expected to finish

2026-12-31

Last updated by the study team

2025-05-15

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• typical findings of PCI on colonoscopy; Line or pebble like sessile cysts are distributed around the colon with normal overlying mucosa

You may not qualify if…

• patients can not take Keishi-ka-shakuyaku-daio-to（TJ-134）

Where it is running

• Showa Inan General hospital — Komagane, Nagano, Japan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.